Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
California, United States
Countries of investment
  • USA
  • Australia
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Fintech
  • Pharmaceuticals
  • Biotechnology
  • HealthCare
  • Wellness
  • Fitness
  • Chemical Products
  • Therapeutics
About
Empath Ventures is a forward-thinking venture capital fund dedicated to advancing the future of psychedelic medicine. With a keen focus on early-stage companies operating at the intersection of psychedelics, neurotechnology, and longevity, the firm aims to enhance the availability of innovative mental health therapies. By leveraging cutting-edge research and fostering transformative ideas, Empath Ventures is committed to unlocking the therapeutic potential of these frontier areas of medicine for improved mental well-being.
Min check size
$25K
Max check size
$6M
Fund size
NPS

Investment Thesis

Empath Ventures focuses on investing in innovative healthcare solutions, particularly in the field of psychedelic medicine and mental health. They aim to back companies that develop clinically effective and accessible treatments for CNS and psychiatric disorders.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp